1st Quarter - Report

THE DUBERSTEIN GROUP INC. for PHRMA INC.

Firm
Client
Income
$75,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

IPAB Bill: S 251/Wyden- Protecting Medicare from Executive Action Act of 2017

LobbyistCovered position, as disclosed
BRIAN GRIFFIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

American Healthcare Act: HR 1628/Black-American Health Care Act of 2017 Drug Re-importation:S 469/Sanders-Affordable and Safe Prescription Drug Importation Act; HR 1245/Cummings:-Affordable and Safe Prescription Drug Importation Act.

LobbyistCovered position, as disclosed
BRIAN GRIFFIN —
DANIEL P MEYER —
ANNE WALL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1245 (115th), H.R. 1628 (115th)

Budget/Appropriations BUD

Budget Funding Issues: S.Con.Res.3/Enzi (SA 178 not agreed to in Senate 46-52 on 1/11/17)

LobbyistCovered position, as disclosed
DAVID J SCHIAPPA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 3 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.